COMMUNIQUÉS West-GlobeNewswire

Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024
28/06/2024
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene [...]
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28/06/2024
BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, reported today that Pyxis [...]
Information on the total number of voting rights and shares
28/06/2024
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 28, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the [...]
Informations sur le nombre total de droits de vote et d'actions
28/06/2024
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 28 juin 2024, 22:30 CET / 16:30h ET – Conformément à l'article 15 de la loi du 2 mai 2007 [...]
GRI Bio Announces Closing of $4.0 Million Public Offering
28/06/2024
LA JOLLA, CA, June 28, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the [...]
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
28/06/2024
CHATHAM, N.J., June 28, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced the closing of its public [...]
NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
28/06/2024
TORONTO and HAIFA, Israel, June 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “ Company ” or “ NurExone ”), a pioneering biopharmaceutical company, is pleased to [...]
Cassava Sciences Issues Statement on Former Science Advisor
28/06/2024
AUSTIN, Texas, June 28, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), reported it has learned today that a federal grand jury returned an indictment charging Hoau-Yan Wang for allegedly defrauding the [...]
Earth Science Tech, Inc., Reports its March 31, 2024, Annual Results, Recording Over $11.9M in Revenue
28/06/2024
Miami, FL, June 28, 2024 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a holding entity currently focused on the health and wellness industry, today shares its financial results and [...]
Nipocalimab pivotal Phase 3 trial demonstrates sustained disease control in FcRn class for a broad population of myasthenia gravis patients
28/06/2024
First FcRn blocker to demonstrate superiority in Myasthenia Gravis - Activities of Daily Living score (MG-ADL) a over placebo when added to standard of care over 24 weeks in antibody positive patients: anti-AChR+, anti- [...]
Results of the Combined General Meeting of 28 June 2024
28/06/2024
Lyon (France) and Cambridge (MA, US), 28 June 2024 - 5.45 pm CEST - PHAXIAM Therapeutics (Euronext: PHXM; FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial [...]
Résultats de l'Assemblée Générale Mixte du 28 juin 2024
28/06/2024
Lyon (France) et Cambridge (MA, US), le 28 juin 2024 – 17h45 CEST – PHAXIAM Therapeutics (Euronext : PHXM ; FR0011471135) société biopharmaceutique qui développe des traitements innovants contre les infections [...]
Higher cantonal composition authority issues written court decision in respect to the amendments to the terms of the 2024 convertible bonds
28/06/2024
Allschwil, Switzerland – June 28, 2024 Idorsia Ltd (SIX: IDIA) today announced that it has received the written decision from the higher cantonal composition authority (obere kantonale Nachlassbehörde) (the Court) in [...]
Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering
28/06/2024
ACTON, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve [...]
Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)
28/06/2024
NEW YORK and WALTHAM, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement [...]
Zealand Pharma major shareholder announcement: Van Herk Investments
28/06/2024
Company announcement – No. 38 / 2024 Zealand Pharma major shareholder announcement: Van Herk Investments Copenhagen, Denmark, 28 June 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a [...]
Total number of shares and voting rights in Zealand Pharma at June 28, 2024
28/06/2024
Company announcement – No. 37 / 2024 Total number of shares and voting rights in Zealand Pharma at June 28, 2024 Copenhagen, Denmark, June 28, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), [...]
Tiziana Receives $3.4 Million in Non-Dilutive Funding
28/06/2024
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough therapies in neurodegenerative disease secondary to [...]
Hapbee Announces Launch of Hapbee Experience At Irish Pub in Partnership with BodyTonic
28/06/2024
Shareholders Elect Two New Directors Following Recent Annual General Meeting VANCOUVER, British Columbia, June 28, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies , Inc. (TSXV: HAPB ) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or [...]

Pages